Gratia Capital, LLC Eloxx Pharmaceuticals, Inc. Transaction History

Gratia Capital, LLC

  • $99.5 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$1.22 - $2.0 $61,000 - $100,000
-50,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.35 - $3.36 $67,500 - $168,000
50,000 New
50,000 $100,000

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Gratia Capital, LLC Portfolio

Follow Gratia Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratia Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratia Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email